curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Sex Hormones Impact on Cannabis Response

by palligoelme@gmail.com | Feb 18, 2026 | Clinical Trials

​ Conditions: Cannabis Interventions: Drug: Cannabis; Drug: Knaster Hemp Sponsors: Maastricht University Recruiting Conditions: Cannabis Interventions: Drug: Cannabis; Drug: Knaster Hemp Sponsors: Maastricht University...

Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients

by palligoelme@gmail.com | Feb 18, 2026 | Clinical Trials

​ Conditions: Cardiac Surgery Associated – Acute Kidney Injury; Critical Illness Interventions: Other: Standard care “bundle” Sponsors: Guowei Tu Not yet recruiting Conditions: Cardiac Surgery Associated – Acute Kidney Injury; Critical Illness...

Effects of Graded Motor Imagery in Individuals With Foot/Ankle Osteoarthritis

by palligoelme@gmail.com | Feb 18, 2026 | Clinical Trials

​ Conditions: Ankle Osteoarthritis; Foot Osteoarthritis Interventions: Behavioral: Exercise Program; Behavioral: Exercise plus graded motor imagery Sponsors: Alanya Alaaddin Keykubat University Recruiting Conditions: Ankle Osteoarthritis; Foot Osteoarthritis...

Persistent COVID-19 Registry in Navarre.

by palligoelme@gmail.com | Feb 18, 2026 | Clinical Trials

​ Conditions: Long COVID Symptoms; Long COVI Sponsors: Fundacion Miguel Servet Recruiting Conditions: Long COVID Symptoms; Long COVI Sponsors: Fundacion Miguel Servet Recruiting 

Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy

by palligoelme@gmail.com | Feb 18, 2026 | Clinical Trials

​ Conditions: Down Syndrome Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting Conditions: Down Syndrome Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet...

A Study of DC6001 Tablet in Healthy Chinese Adult Subjects

by palligoelme@gmail.com | Feb 18, 2026 | Clinical Trials

​ Conditions: Stargardt Disease Interventions: Drug: DC6001; Drug: Placebo Sponsors: Heronova Pharmaceuticals Recruiting Conditions: Stargardt Disease Interventions: Drug: DC6001; Drug: Placebo Sponsors: Heronova Pharmaceuticals...
« Older Entries
Next Entries »

Recent Posts

  • Intravascular Ultrasound- and Angiography-Derived Fractional Flow Reserve-Guided Drug-Coated Balloon for Large Coronary Artery De Novo Lesions
  • Gummy Smile and Altered Passive Eruption Prevalence
  • Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.
  • A Study in Adults With Desmoid Tumors
  • Best Possible Self-Tech for Middle Schoolers

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®